KeViRx, Inc. is a preclinical stage pharmaceutical company headquartered in Charlottesville, VA. We are developing small molecules drugs that treat microvascular leakage and inflammation, pathologies that are the basis for many diseases, including cancer and respiratory disease. We are now entering IND-enabling studies for pulmonary microvascular leakage and inflammation during acute lung injury. Our lead asset, KVX-053 has potent anti-inflammatory and immunomodulatory effects. In preclinical models, KVX-053 reduces lung injury scoring & the biomarkers of lung injury, inflammation & proinflammatory cytokine release, & immune cell infiltration into the lung. KVX-053 also improves lung function after lung injury. Contact us for more information at info@KeViRx.com.
External link for KeViRx, Inc.
Charlottesville, VA 22904, US
Team KeViRx is delighted to be presenting at the Frontier BioHealth by Activation Capital Startup Showcase!! Hope you can join to see and listen to pitches from 10 amazing companies! https://lnkd.in/gPQyMmU7
This content isn’t available here
Access this content and more in the LinkedIn app
Team KeViRx is honored to be highlighted in an article by Richmond Inno! Thank you Cassidy Mantor for giving us the opportunity to discuss our small molecule technology and our mission to transform patient care for acute lung injury! For more information, check out the article here: https://lnkd.in/ebPHBZqG
Team KeViRx is delighted to announce their attendance at the JLABS CEO Summit on October 21-23, 2024! We are excited to connect with fellow leaders, share insights, and explore innovative ideas. We are looking forward to engaging with the entrepreneurial community at this exciting event. #JLABS #CEOSummit
Team KeViRx is thrilled to attend the BARDA Innovation Symposium on November 6, 2024 in Washington, DC! We are looking forward to learning about early-stage health security innovations and networking with innovators, funders, and industry partners. For details, visit: https://lnkd.in/e_q8pEpF
Honored to be part of the 2025 class of SLAS Fellows! For more details see: https://lnkd.in/eVQW2F2j
Team KeViRx is looking forward to connecting at the Wilson Sonsini Biotech Summit in Boston, MA! Hope to see you and talk to you there! https://lnkd.in/eaw8scVR
Check out the latest press release from Activation Capital featuring their Frontier BioHealth program! Meet the cohort of 10 selected startups for the inaugural program. KeViRx is excited to be part of this group! Learn more here: https://lnkd.in/gaZjintK
Check out our latest manuscript published in JPET! 📚 Congratulations to our collaborators at Old Dominion University - Pavel Solopov, Ruben Biancatelli, Tierney Day, Betsy Gregory, and John Catravas - for their fabulous work! 🎉 Link to the manuscript: [Read more here](https://lnkd.in/ewKdENNf) 🌟 #JPET #OldDominionUniversity #KeViRx
Team KeViRx is very excited to be part of Activation Capital's Frontier BioHealth program! We are honored to learn with, and from, such a talented group of biotech founders! See link for details! https://lnkd.in/eR2vuwMX #FrontierBioHealth #ActivationCapital
🚀 What an amazing start to Frontier BioHealth! Last Thursday and Friday, we kicked off an incredible journey with our inaugural cohort of 10 groundbreaking startups, poised to revolutionize life sciences innovation. The kickoff event was hosted at the VA Bio+Tech Park, providing the perfect backdrop for this exciting launch. Meet our cohort: Atticus Pharma, GenAssist, Gisens Biotech, KeViRx, Inc., Light Switch Bio, Oncoustics, OrthoPreserve, Pele Therapeutics, Rapid Forensic Cell Typing, Inc, and Vizma.AI. A special thank you to our national partners, gener8tor, Fat Robin, and FedTech for their invaluable support and collaboration. We also want to express our gratitude to our guest speakers and everyone who joined us—your energy and ideas are shaping the future of health. Here’s to new beginnings and groundbreaking discoveries! 🧬 If you're interested in learning more about the program or mentoring opportunities, please visit: https://lnkd.in/eWRg5Csq Funded [in part] through a Grant with the U.S. Small Business Administration. #FrontierBioHealth #ActivationCapital #VABioTechPark #InnovationEcosystem #Innovation #Entrepreneurship #Startups #LifeSciences #Healthcare #Pharmaceutical #BioTech #MedicalDevice
Some super exciting news! JLABS-DC hit their 3rd anniversary and several JLABS-DC resident companies recently acquired more funding! Sounds like a major boost for innovation in healthcare and biotech. Here's to continued success and breakthroughs! Learn more at: https://lnkd.in/gEz7H3gE